Effects of multimorbidity on incident COVID‐19 events and its interplay with COVID‐19 event status on subsequent incident myocardial infarction (MI) — Professor Gregory Lip (2022) | RDL Network
The very large investigation conducted herein confirmed the importance of cardiometabolic and noncardiometabolic multimorbidity in increasing vulnerabilities to a higher risk of COVID-19 infections. Furthermore, the presence of COVID-19 infections increased incident MI complications both in terms of independent effects and interactions with the multimorbid profile and age.
Karola Jering, B Claggett, Michael Pfeffer, Claire Granger, Lars Køber, Eldrin F. Lewis, Aldo Maggioni, Douglas L. Mann, John J.V. McMurray, M F Prescott, Joëlle Rouleau, Scott D. Solomon, Philippe Gabríel Steg, Dirk von Lewinski, Eugene Braunwald
J. Wouter Jukema, Tamara B. Harris, Majken K. Jensen, Guðný Eiríksdóttir, Ramachandran S. Vasan, Stefan Blankenberg, Paul M. Ridker, Kent D. Taylor, Albert V. Smith, Lynda M. Rose, David J. Stott, Susan R. Heckbert, Bruce M. Psaty, Kenneth Rice, Philippe Amouyel, Stella Trompet, Cynthia J. Girman, Juha Karvanen, Henry Völzke, Eric B. Rimm, Kari Kuulasmaa, Stephen B. Kritchevsky, David S. Siscovick,
Discussion(0)
No comments yet. Be the first to comment.